Genornic stability and tumorigenesis

被引:41
作者
Sieber, O
Heinimann, K
Tomlinson, I
机构
[1] Canc Res UK, London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England
[2] Univ Basel, Childrens Hosp, Dept Res & Clin Biol Sci, Div Med Genet,Res Grp Human Genet, CH-4058 Basel, Switzerland
关键词
DNA; mutation; tumorigenesis;
D O I
10.1016/j.semcancer.2004.09.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer research needs to explain the observed incidence of cancer. Many factors determine this process, including: the number of susceptible cells in the tissue of origin; the number of normal cell divisions through which susceptible cells pass in normal development and turnover; the number of cell divisions during tumorigenesis: the selective advantage which tumour cells have acquired: the ease of detection of a cancer: the number of mutations which are required for malignancy:. the possible stepwise nature of tumorigenesis; the value of the normal mutation rate; the presence of extrinsic factors such as mutagens or growth promoters; the presence and strength of genomic instability, a phenomenon which has received a great deal of attention. We know very little about most of the factors and their influence in humans. We cannot, therefore, readily answer the question as to whether or not the observed incidence of cancer is what we would expect. Specifically, it is not yet posssible to assess whether or not genomic instability is a prerequisite for carcinogenesis. Mathematical models, which assess the importance of genomic instability in tumorigenesis can be helpful, but require interpretation in the context of our overall ignorance. Experimental data have shown genomic instability in some cancers, but we do not yet know whether or not hypermutation initiates and drives tumorigenesis (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 59 条
  • [1] THE AGE DISTRIBUTION OF CANCER AND A MULTI-STAGE THEORY OF CARCINOGENESIS
    ARMITAGE, P
    DOLL, R
    [J]. BRITISH JOURNAL OF CANCER, 1954, 8 (01) : 1 - 12
  • [2] Bodmer WF, 1996, CIBA F SYMP, V197, P181
  • [3] BODMER WF, 1996, CIBA FOUND S, V197, P289
  • [4] Chromosome abnormalities in colorectal adenomas: Two cytogenetic subgroups characterized by deletion of 1p and numerical aberrations
    Bomme, L
    Bardi, G
    Pandis, N
    Fenger, C
    Kronborg, O
    Heim, S
    [J]. HUMAN PATHOLOGY, 1996, 27 (11) : 1192 - 1197
  • [5] Cytogenetic analysis of colorectal adenomas: Karyotypic comparisons of synchronous tumors
    Bomme, L
    Bardi, G
    Pandis, N
    Fenger, C
    Kronborg, O
    Heim, S
    [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 106 (01) : 66 - 71
  • [6] CLONAL KARYOTYPIC ABNORMALITIES IN COLORECTAL ADENOMAS - CLUES TO THE EARLY GENETIC EVENTS IN THE ADENOMA-CARCINOMA SEQUENCE
    BOMME, L
    BARDI, G
    PANDIS, N
    FENGER, C
    KRONBORG, O
    HEIM, S
    [J]. GENES CHROMOSOMES & CANCER, 1994, 10 (03) : 190 - 196
  • [7] Colorectal pretumor progression before and after loss of DNA mismatch repair
    Calabrese, P
    Tsao, JL
    Yatabe, Y
    Salovaara, R
    Mecklin, JP
    Järvinen, HJ
    Aaltonen, LA
    Tavaré, S
    Shibata, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) : 1447 - 1453
  • [8] Genomic instability and cancer
    Charames, GS
    Bapat, B
    [J]. CURRENT MOLECULAR MEDICINE, 2003, 3 (07) : 589 - 596
  • [9] Esteller M, 2001, CANCER RES, V61, P4689
  • [10] hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis
    Esteller, M
    Catasus, L
    Matias-Guiu, X
    Mutter, GL
    Prat, J
    Baylin, SB
    Herman, JG
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (05) : 1767 - 1772